Axillary accessory breast cancer with persistent leftsuperior vena cava: A case report and treatment controversy
| Autor: | Jun Zhang, Weidong Zhang, Yunbo Pan, Meilin Min |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Persistent left superior vena cava Sentinel lymph node Treatment controversy Article 03 medical and health sciences 0302 clinical medicine Biopsy Case report medicine skin and connective tissue diseases medicine.diagnostic_test business.industry Axillary Lymph Node Dissection Cancer medicine.disease Accessory breast Accessory breast cancer 030220 oncology & carcinogenesis Adenocarcinoma 030211 gastroenterology & hepatology Surgery Histopathology Radiology business |
| Zdroj: | International Journal of Surgery Case Reports |
| ISSN: | 2210-2612 |
| Popis: | Highlights • Accessory breast cancer with persistent left superior vena cava(PLSVC) is rare. • The treatments of axillary accessory breast cancer should attract our attention. • Patients with accessory breast cancer without breast invasion should undergo local enlarged resection and axillary lymph node dissection (ALND). • We recommend routine axillary radiotherapy after accessory breast cancer surgery. • It is imperative to organize multi-center accessory breast cancer research. Introduction Axillary accessory breast cancer and persistent left superior vena cava (PLSVC) are rare clinically. Many controversial treatments for accessory breast cancer are worth discussing and learning. Presentation of the case A 48-year-old woman presented with biopsy histopathology confirmed. Right axillary mass biopsy pathology showed mucinous adenocarcinoma of accessory breast. She concerned that the axillary accessory breast cancer was more likely to metastasize and unsure about whether to remove the breast. She accepted extended right axillary accessory breast resection plus ipsilateral axillary lymph node dissection (ALND) and received chemotherapy. She was found to have a PLSVC before chemotherapy. Discussion Is there a need to remove the breast and perform ALND during axillary accessory breast cancer surgery? Is sentinel lymph node biopsy (SLNB) appropriate for axillary accessory breast cancer surgery? Can negative SLNB for axillary accessory breast cancer avoid ALND? Does accessory breast cancer without axillary lymph node metastasis require local radiotherapy? Does PLSVC impact the use of peripherally inserted central catheters (PICC) tubes during chemotherapy? Patients with accessory breast cancer without breast invasion should undergo local extended resection and ALND. SLNB for accessory breast cancer cannot instead of ALND. We recommend routine axillary radiotherapy after accessory breast cancer surgery. If it is determined that the tip of PICC is not in the coronary sinus of PLSVC, PLSVC does not affect chemotherapy. Conclusion Many treatment strategies for accessory breast cancer require more evidence from evidence-based medicine. It is imperative to conduct multi-center accessory breast cancer research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|